{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:41Z","timestamp":1786118921227,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1524-4725.2008.34202.x","type":"journal-article","created":{"date-parts":[[2008,4,22]],"date-time":"2008-04-22T17:13:16Z","timestamp":1208884396000},"page":"1032-1040","source":"Crossref","is-referenced-by-count":13,"title":["Comparative Evaluation of Beneficiary Effects of Priming Agents (2% Hydroquinone and 0.025% Retinoic Acid) in the Treatment of Melasma with Glycolic Acid Peels"],"prefix":"10.1097","volume":"34","author":[{"given":"VIJAY KUMAR","family":"GARG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RASHMI","family":"SARKAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RUCHI","family":"AGARWAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2008,4,22]]},"reference":[{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB1|cit2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0733-8635(05)70150-9","article-title":"Disorders of hyperpigmentation","volume":"18","author":"Pandya","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB2|cit3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00042728-200302000-00022","article-title":"Melasma in Indian males","volume":"29","author":"Sarkar","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB3|cit4","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archderm.1995.01690240119022","article-title":"Melasma","volume":"131","author":"Grimes","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB4|cit5","first-page":"897","article-title":"Treatment of melasma","volume":"37","author":"Piamphongsant","year":"1998","journal-title":"a review with personal experience"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB5|cit6","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/j.jaad.2005.12.039","article-title":"Treatment of melasma","volume":"54","author":"Rendon","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB6|cit7","first-page":"97","article-title":"Melasma","volume":"2","author":"Victor","year":"2004","journal-title":"a review"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB7|cit8","first-page":"17","volume-title":"Manual of chemical peels. Superficial and medium depth","author":"Rubin","year":"1995"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB8|cit9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-4362.2001.01149.x","article-title":"Safety and efficacy of glycolic acid facial peel in Indian women with melasma","volume":"40","author":"Javaheri","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB9|cit10","first-page":"828","article-title":"The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark skinned patients","volume":"28","author":"Sarkar","year":"2002","journal-title":"a comparative study"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB10|cit11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1524-4725.1999.08145.x","article-title":"The safety and efficacy of salicylic acid chemical peels in darker racial ethnic groups","volume":"25","author":"Grimes","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB11|cit12","first-page":"385","article-title":"Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma","volume":"30","author":"Nanda","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB12|cit13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archderm.1994.01690060057005","article-title":"Topical retinoic acid (tretinoin) for melasma in black patients","volume":"130","author":"Candance","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB13|cit14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1524-4725.1997.tb00014.x","article-title":"Glycolic acid peels for postinflammatory hyperpigmentation in black patients","volume":"23","author":"Burns","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1524-4725.2008.34202.x-BIB14|cit15","first-page":"385","article-title":"Commentary. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma","volume":"30","author":"Monheit","year":"2004","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1111\/j.1524-4725.2008.34202.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:07Z","timestamp":1786036027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1111\/j.1524-4725.2008.34202.x"}},"subtitle":["PRIMING AGENTS FOR MELASMA"],"short-title":[],"issued":{"date-parts":[[2008,4,22]]},"references-count":14,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.1111\/j.1524-4725.2008.34202.x","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4,22]]}}}